SharonAI Updates Resale Prospectus with Q2 Financials and Material Weakness Disclosure
SHAZ has more than doubled off its 52-week low of $16.55.
Summary
SharonAI's latest prospectus supplement adds Q2 2026 financials showing a $430.4M net loss and a material weakness in internal controls, while updating total contract value to $8.8B.
Key Events · Financing and Capital Events · SHAZ
-
Q2 Net Loss of $430.4M
Net loss of $430.4 million for Q2 2026, including a $400.4 million non-cash fair value loss on convertible notes driven by share price appreciation.
-
Material Weakness in Internal Controls
Management disclosed a material weakness in internal control over financial reporting related to accounting for complex financial instruments, which continued as of June 30, 2026.
-
Total Contract Value Reaches $8.8B
Total contract value of approximately $8.8 billion as of August 6, 2026, including new contracts with a global AI lab ($1.32B) and a global AI platform ($373M).
-
Resale Registration Updated
Prospectus supplement updates the resale registration for over 5.3 million shares, now incorporating the Q2 2026 financial statements and disclosures.
Analysis · SHAZ · Technology
This prospectus supplement attaches the Q2 2026 10-Q and 10-Q/A, revealing a $430.4 million net loss driven by a $400.4 million non-cash fair value loss on convertible notes as the share price rose. It also discloses a continuing material weakness in internal control over financial reporting related to complex financial instruments. These are material new facts for investors evaluating the resale of over 5.3 million shares and the company's financial health.
At the time of this filing, SHAZ was trading at $72.15 on NASDAQ in the Technology sector, with a market capitalization of approximately $2.6B. The 52-week trading range was $16.55 to $97.48. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.